- Home
- IOTR vs RVPH Comparison
IOTR vs RVPH Comparison
Compare IOTR & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOTR
- RVPH
- Stock Information
- Founded
- IOTR 2019
- RVPH 2006
- Country
- IOTR Singapore
- RVPH United States
- Employees
- IOTR N/A
- RVPH N/A
- Industry
- IOTR
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- IOTR
- RVPH Health Care
- Exchange
- IOTR NYSE
- RVPH Nasdaq
- Market Cap
- IOTR 29.5M
- RVPH 32.8M
- IPO Year
- IOTR 2025
- RVPH N/A
- Fundamental
- Price
- IOTR $0.45
- RVPH $0.40
- Analyst Decision
- IOTR
- RVPH Strong Buy
- Analyst Count
- IOTR 0
- RVPH 5
- Target Price
- IOTR N/A
- RVPH $9.00
- AVG Volume (30 Days)
- IOTR 331.4K
- RVPH 3.4M
- Earning Date
- IOTR 01-01-0001
- RVPH 08-13-2025
- Dividend Yield
- IOTR N/A
- RVPH N/A
- EPS Growth
- IOTR N/A
- RVPH N/A
- EPS
- IOTR N/A
- RVPH N/A
- Revenue
- IOTR $10,478,550.00
- RVPH N/A
- Revenue This Year
- IOTR N/A
- RVPH N/A
- Revenue Next Year
- IOTR N/A
- RVPH N/A
- P/E Ratio
- IOTR N/A
- RVPH N/A
- Revenue Growth
- IOTR 22.27
- RVPH N/A
- 52 Week Low
- IOTR $0.31
- RVPH $0.30
- 52 Week High
- IOTR $5.98
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- IOTR N/A
- RVPH 33.44
- Support Level
- IOTR N/A
- RVPH $0.35
- Resistance Level
- IOTR N/A
- RVPH $0.83
- Average True Range (ATR)
- IOTR 0.00
- RVPH 0.06
- MACD
- IOTR 0.00
- RVPH -0.01
- Stochastic Oscillator
- IOTR 0.00
- RVPH 17.36
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.